Biography
Professional Summary
Education & Certifications
- Medical Education: Stanford University School of Medicine (2007) CA
- Internship: Santa Clara Valley Medical Center (2008) CA
- Residency: Stanford University Dept of Dermatology (2011) CA
-
- Board Certification: American Board of Dermatology, Dermatology (2011)
Publications
-
Automated diagnosis of data-model conflicts using metadata
Chen, R. O., & Altman, R. B. (1999). Automated diagnosis of data-model conflicts using metadata. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 6(5), 374–92. -
The direct cellular target of topically applied pimecrolimus may not be infiltrating lymphocytes
Fiorentino, D. F., Chen, R. O., STEWART, D. B., Brown, K. K., & Sundram, U. N. (2011). The direct cellular target of topically applied pimecrolimus may not be infiltrating lymphocytes. BRITISH JOURNAL OF DERMATOLOGY, 164(5), 996–1003. -
Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts
Lee, C. S., Ungewickell, A., Bhaduri, A., Qu, K., Webster, D. E., Armstrong, R., … Khavari, P. A. (2012). Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts. BLOOD, 120(16), 3288–97. -
-
Computational methods for defining the allowed conformational space of 16S rRNA based on chemical footprinting data
Fink, D. L., Chen, R. O., Noller, H. F., & Altman, R. B. (1996). Computational methods for defining the allowed conformational space of 16S rRNA based on chemical footprinting data. RNA-A PUBLICATION OF THE RNA SOCIETY, 2(9), 851–66. -
Constraining volume by matching the moments of a distance distribution
Chen, C. C., Chen, R. O., & Altman, R. B. (1996). Constraining volume by matching the moments of a distance distribution. COMPUTER APPLICATIONS IN THE BIOSCIENCES, 12(4), 319–26. -
RNA secondary structure as a reusable interface to biological information resources
Felciano, R. M., Chen, R. O., & Altman, R. B. (1997). RNA secondary structure as a reusable interface to biological information resources. GENE-COMBIS, 190, GC59–GC70. -
Standardized representations of the literature: Combining diverse sources of ribosomal data
Altman, R. B., Abernethy, N. F., & Chen, R. O. (1997). Standardized representations of the literature: Combining diverse sources of ribosomal data. Presented at the 5th International Conference on Intelligent Systems for Molecular Biology (ISMB-97), HALKIDIKI,GREECE: AMER ASSOC ARTIFICIAL INTELLIGENCE. -
RIBOWEB: Linking structural computations to a knowledge base of published experimental data
Chen, R. O., Felciano, R., & Altman, R. B. (1997). RIBOWEB: Linking structural computations to a knowledge base of published experimental data. Presented at the 5th International Conference on Intelligent Systems for Molecular Biology (ISMB-97), HALKIDIKI,GREECE,GREECE,GREECE,GREECE,GREECE,GREECE: AMER ASSOC ARTIFICIAL INTELLIGENCE. -
Achieving high-sensitivity for clinical applications using augmented exome sequencing.
Patwardhan, A., Harris, J., Leng, N., Bartha, G., Church, D. M., Luo, S., … Chen, R. (2015). Achieving high-sensitivity for clinical applications using augmented exome sequencing. Genome Medicine, 7(1), 71-? -
Achieving high-sensitivity for clinical applications using augmented exome sequencing
Patwardhan, A., Harris, J., Leng, N., Bartha, G., Church, D. M., Luo, S., … Chen, R. (2015). Achieving high-sensitivity for clinical applications using augmented exome sequencing. GENOME MEDICINE, 7. -
Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing
Shoemaker, L. D., Clark, M. J., Patwardhan, A., Chandratillake, G., Garcia, S., Chen, R., … Steinberg, G. K. (2016). Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing. G3-GENES GENOMES GENETICS, 6(1), 41–49. -
Genetic analysis in a patient with nine primary malignant neoplasms: A rare case of Li-Fraumeni syndrome
Li, X., Kang, J., Pan, Q., Sikora-Wohlfeld, W., Zhao, D., Meng, C., … Ding, K. (2016). Genetic analysis in a patient with nine primary malignant neoplasms: A rare case of Li-Fraumeni syndrome. ONCOLOGY REPORTS, 35(3), 1519–28. -
Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing.
Shoemaker, L. D., Clark, M. J., Patwardhan, A., Chandratillake, G., Garcia, S., Chen, R., … Steinberg, G. K. (2015). Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing. G3 (Bethesda, Md.), 6(1), 41–49. -
Constraints on Biological Mechanism from Disease Comorbidity Using Electronic Medical Records and Database of Genetic Variants
Bagley, S. C., Sirota, M., Chen, R., Butte, A. J., & Altman, R. B. (2016). Constraints on Biological Mechanism from Disease Comorbidity Using Electronic Medical Records and Database of Genetic Variants. PLOS COMPUTATIONAL BIOLOGY, 12(4). -
Early somatic mosaicism is a rare cause of long-QT syndrome
Priest, J. R., Gawad, C., Kahlig, K. M., Yu, J. K., O'Hara, T., Boyle, P. M., … Ashley, E. A. (2016). Early somatic mosaicism is a rare cause of long-QT syndrome. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 113(41), 11555–60. -
Are minor alleles more likely to be risk alleles?
Kido, T., Sikora-Wohlfeld, W., Kawashima, M., Kikuchi, S., Kamatani, N., Patwardhan, A., … Butte, A. J. (2018). Are minor alleles more likely to be risk alleles? BMC MEDICAL GENOMICS, 11, 3. -
Genetic analysis in a patient with nine primary malignant neoplasms: a rare case of Li-Fraumeni syndrome.
Li, X., Kang, J., Pan, Q., Sikora-Wohlfeld, W., Zhao, D., Meng, C., … Ding, K. (2016). Genetic analysis in a patient with nine primary malignant neoplasms: a rare case of Li-Fraumeni syndrome. Oncology Reports, 35(3), 1519–28. -
Exome scale liquid biopsy monitoring of putative neoantigens and genomic biomarkers in patients on anti-PD-1 therapy in squamous cell carcinoma of the head and neck.
Abbott, C. W., Bedi, N., Zhang, S. V., Li, R., Pyke, R. M., Levy, E., … Boyle, S. M. (2020). Exome scale liquid biopsy monitoring of putative neoantigens and genomic biomarkers in patients on anti-PD-1 therapy in squamous cell carcinoma of the head and neck. CANCER IMMUNOLOGY RESEARCH. AMER ASSOC CANCER RESEARCH. -
Exome scale liquid biopsy characterization of putative neoantigens and genomic biomarkers pre- and post anti-PD-1 therapy in squamous cell carcinoma of the head and neck.
Abbott, C., Bedi, N., Zhang, S., Li, R., Pyke, R., Levy, E., … Boyle, S. M. (2020). Exome scale liquid biopsy characterization of putative neoantigens and genomic biomarkers pre- and post anti-PD-1 therapy in squamous cell carcinoma of the head and neck. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY. -
Sensitive HLA loss of heterozygosity detection reveals allele-specific neoantigen expansion as resistance mechanism to anti-PD-1 therapy
Pyke, R. M., Abbott, C., Mellacheruvu, D., Zhang, S., Bedi, N., Colevas, A. D., … Boyle, S. M. (2020). Sensitive HLA loss of heterozygosity detection reveals allele-specific neoantigen expansion as resistance mechanism to anti-PD-1 therapy. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH. -
Precision neoantigen discovery using large-scale immunopeptidomes and composite modeling of MHC peptide presentation.
Pyke, R. M., Mellacheruvu, D., Dea, S., Abbott, C., Zhang, S. V., Phillips, N. A., … Boyle, S. M. (2021). Precision neoantigen discovery using large-scale immunopeptidomes and composite modeling of MHC peptide presentation. Molecular & Cellular Proteomics : MCP, 100111. -
Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms.
Abbott, C. W., Boyle, S. M., Pyke, R. M., McDaniel, L. D., Levy, E., Navarro, F. C., … Chen, R. (2021). Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 27(15), 4265–4276. -
Pan-cancer survey of HLA loss of heterozygosity using a robustly validated NGS-based machine learning algorithm.
Pyke, R. M., Mellacheruvu, D., Abbott, C., Dea, S., Levy, E., Zhang, S. V., … Boyle, S. M. (2021). Pan-cancer survey of HLA loss of heterozygosity using a robustly validated NGS-based machine learning algorithm. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH. -
Longitudinal exome-scale liquid biopsy monitoring of evolving therapeutic resistance mechanisms in head and neck squamous cell carcinoma patients receiving anti-PD-1 therapy.
Abbott, C. W., Bedi, N., Zhang, S. V., Northcott, J., Li, R., Pyke, R. M., … Chen, R. (2021). Longitudinal exome-scale liquid biopsy monitoring of evolving therapeutic resistance mechanisms in head and neck squamous cell carcinoma patients receiving anti-PD-1 therapy. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH. -
Association of HLA loss of heterozygosity with allele-specific neoantigen expansion in response to immunotherapy.
Pyke, R. M., Abbott, C., Dea, S., Bedi, N., Colevas, A. D., Levy, E., … Boyle, S. M. (2021). Association of HLA loss of heterozygosity with allele-specific neoantigen expansion in response to immunotherapy. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Robust prediction of response to immunotherapy in a mixed cohort of previously treated and immunotherapy-naive melanoma patients.
Abbott, C., McDaniel, L., Pyke, R., Levy, E., Navarro, F., Wang, S. V. Z. J., … Chen, R. (2021). Robust prediction of response to immunotherapy in a mixed cohort of previously treated and immunotherapy-naive melanoma patients. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
TUMOR-INFORMED LIQUID BIOPSY MONITORING OF EVOLVING THERAPEUTIC RESISTANCE MECHANISMS IN HEAD AND NECK SQUAMOUS CELL CARCINOMA PATIENTS RECEIVING ANTI-PD-1 THERAPY
Abbott, C., Bedi, N., Wang, J., Northcott, J., Pyke, R., Li, R., … Chen, R. (2021). TUMOR-INFORMED LIQUID BIOPSY MONITORING OF EVOLVING THERAPEUTIC RESISTANCE MECHANISMS IN HEAD AND NECK SQUAMOUS CELL CARCINOMA PATIENTS RECEIVING ANTI-PD-1 THERAPY. JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMJ PUBLISHING GROUP. -
EXTENSIVELY VALIDATED HLA LOH ALGORITHM DEMONSTRATES AN ASSOCIATION BETWEEN HLA LOH AND GENOMIC INSTABILITY
Pyke, R., Dea, S., Mellacheruvu, D., Abbott, C., Zhang, S., McDaniel, L., … Boyle, S. (2021). EXTENSIVELY VALIDATED HLA LOH ALGORITHM DEMONSTRATES AN ASSOCIATION BETWEEN HLA LOH AND GENOMIC INSTABILITY. JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMJ PUBLISHING GROUP. -
A machine learning algorithm with subclonal sensitivity reveals widespread pan-cancer human leukocyte antigen loss of heterozygosity.
Pyke, R. M., Mellacheruvu, D., Dea, S., Abbott, C. W., McDaniel, L., Bhave, D. P., … Boyle, S. M. (2022). A machine learning algorithm with subclonal sensitivity reveals widespread pan-cancer human leukocyte antigen loss of heterozygosity. Nature Communications, 13(1), 1925. -
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.
Padron, L. J., Maurer, D. M., O'Hara, M. H., O'Reilly, E. M., Wolff, R. A., Wainberg, Z. A., … Vonderheide, R. H. (2022). Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial. Nature Medicine. -
Distinct biosignatures associate with survival after chemoimmunotherapy in a randomized, three-arm phase II study in patients with metastatic pancreatic cancer.
Padron, L. J., Maurer, D. M., O'Hara, M. H., O'Reilly, E. M., Wolff, R. A., Wainberg, Z. A., … Vonderheide, R. H. (2022). Distinct biosignatures associate with survival after chemoimmunotherapy in a randomized, three-arm phase II study in patients with metastatic pancreatic cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
-
Computational methods for defining the allowed conformational space of 16S rRNA based on chemical footprinting data
Practice Locations
General Dermatology Clinic in Redwood City Redwood City, CA
Redwood City, CAGeneral Dermatology Clinic in Redwood City
450 Broadway Street, Pavilion B 4th Floor
Redwood City , CA 94063
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(103 reviews)
View More
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records